ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers

Picture of a hand with a blue glove holding a bottle of a vaccine

12/09/2022 – Antwerp, BelgiumThe Belgian university spin-off received a development grant totalling to € 130.000 to further develop their VaccineWatch platform. The company specialises in monitoring and predicting immune responses using artificial intelligence. VLAIO’s support is used to make this technology available to vaccine developers. In recent years, we are seeing a rising interest in […]